Clinical Trial Update: Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on peri-operative sintilimab combined with SOX chemotherapy for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• SOX (SOX)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer, Perioperative | Phase 2 | Status: UNKNOWN